Lastly, we performed multiplex immunofluorescence assay to quantify the protein expression of these lymphocyte subsets in the LSM-low and LSM-high subgroups in patients with EGFR-TKI-resistant NSCLC (Figures 7A–7F). This evidence concerns the gene EGFR and non-small cell lung carcinoma.